In the public interest, ministers need the advice they receive on matters relating to the regulation of medicines and medical devices to be impartial. They also need to be able to seek such advice from a wide range of highly skilled professionals who are senior and well regarded in their respective fields and from a range of appointed lay and patient representatives.
A number of independent advisory committees have been established to provide such an advice. These committees can also establish working group to address specific problems. Members of these committees may receive a fee and claim some expenses. This section sets out details about the terms of references of these various committees, their members and the work they undertake.
Latest committee documents
04 Jun 2014 | Pharmacovigilance Expert Advisory Group summary minutes - 4 June 2014 (28Kb)
15 May 2014 | Commission on Human Medicines minutes - 15 May 2014 (62Kb)
30 Apr 2014 | Pharmacovigilance Expert Advisory Group summary minutes - 30 April 2014 (30Kb)
17 Apr 2014 | Commission on Human Medicines minutes - 17 April 2014 (51Kb)
03 Apr 2014 | Pharmacovigilance Expert Advisory Group summary minutes - 3 April 2014 (28Kb)
13 Mar 2014 | Commission on Human Medicines minutes - 13 and 14 March 2014 (492Kb)
10 Mar 2014 | Clinical Trials Expert Advisory Group summary minutes - 10 March 2014 (49Kb)
06 Mar 2014 | Oncology and Haematology Expert Advisory Group summary minutes - 6 March 2014 (30Kb)
Expert Group on innovation in the regulation of healthcare
Medicines Industry Liaison Group
Medicines advisory bodies
The medicines advisory bodies were introduced under the Medicines Act 1968. They provide advice to ministers (who are the Licensing Authority) on aspects of medicines regulation.